# Nouscom

**Source:** https://www.startuphub.ai/startups/nouscom
**Profile type:** Startup

> clinical-stage, cancer interception focused BioTech developing next-generation immunotherapies

## About

Founded in 2015, Nouscom is a clinical-stage BioTech company innovating next-generation neoantigen-targeted immunotherapies to treat cancer at all stages, from early cancer interception to late-stage metastatic disease. Its proprietary viral vector platform enables broad and durable immune activation by delivering optimised neoantigens that train the immune system to recognise and fight cancer.

## Key facts

- **Slug:** nouscom
- **Website:** https://nouscom.com
- **Location:** Basel, Switzerland
- **Founded:** 2015-01-01
- **Operating status:** Active
- **Total funding:** $130M
- **Sectors / tags:** Biotechnology, Healthcare

## StartupHub.ai scores

- **Ahrefs DR:** 30/100
- **Effective DR:** 28/100
- **Agent Readiness:** D (42/100)
- **Site Speed:** 60/100
- **Data Trust:** 77/100

## Funding rounds

| Date | Round | Amount | Lead investors |
| --- | --- | --- | --- |
| 1 Oct 2026 | [Series D](https://www.startuphub.ai/investment_rounds/nouscom-series-d-2026) | $130M | [M-Ventures](https://www.startuphub.ai/investors/m-ventures) |

## Tech stack

Detected on nouscom.com, last scanned 2026-10-19.

- **Hosting:** Google Cloud

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Nouscom",
          "item": "https://www.startuphub.ai/startups/nouscom"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/nouscom#webpage",
      "url": "https://www.startuphub.ai/startups/nouscom",
      "name": "Nouscom - AI Startup Profile | StartupHub.ai",
      "description": "This is the StartupHub.ai profile of Nouscom. Nouscom is a startup founded in 2015, operating in Biotechnology and Healthcare. clinical-stage, cancer interception focused BioTech developing next-generation immunotherapies. Headquartered in Basel, Switzerland.",
      "dateModified": "2026-10-19T08:59:56.310Z",
      "mainEntity": {
        "@type": "Organization",
        "@id": "https://www.startuphub.ai/startups/nouscom#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/nouscom#organization",
      "name": "Nouscom",
      "url": "https://nouscom.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/a609a9cb-4bef-4c77-b874-5a9742dad561-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/a609a9cb-4bef-4c77-b874-5a9742dad561-square.webp",
      "description": "Founded in 2015, Nouscom is a clinical-stage BioTech company innovating next-generation neoantigen-targeted immunotherapies to treat cancer at all stages, from early cancer interception to late-stage metastatic disease. Its proprietary viral vector platform enables broad and durable immune activation by delivering optimised neoantigens that train the immune system to recognise and fight cancer.",
      "foundingDate": "2015-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Basel",
        "addressCountry": "Switzerland"
      },
      "knowsAbout": [
        "Biotechnology",
        "Healthcare"
      ]
    }
  ]
}
```